Haleon plc

LSE (GBp): Haleon plc (HLN)

Last Price

379.40

Today's Change

+1.40 (0.37%)

Day's Change

374.10 - 379.50

Trading Volume

9,416,834

Overview

Market Cap

34 Billion

Shares Outstanding

9 Billion

Avg Volume

22,651,879

Avg Price (50 Days)

376.46

Avg Price (200 Days)

362.38

PE Ratio

29.18

EPS

0.13

Earnings Announcement

27-Feb-2025

Previous Close

378.00

Open

374.70

Day's Range

374.1 - 379.5

Year Range

308.37 - 400.649

Trading Volume

9,416,834

Price Change Highlight

1 Day Change

0.37%

5 Day Change

1.20%

1 Month Change

-0.50%

3 Month Change

4.43%

6 Month Change

1.55%

Ytd Change

0.16%

1 Year Change

17.46%

3 Year Change

23.04%

5 Year Change

23.04%

10 Year Change

23.04%

Max Change

23.04%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment